Wound Healing is a complex and dynamic process that aims to restore the structural and functional integrity of damaged tissues. It typically occurs in four overlapping phases: hemostasis, inflammation, proliferation, and remodeling. Hemostasis involves the immediate response to injury, where blood vessels constrict, and platelets form a clot to minimize blood loss. The inflammatory phase follows, characterized by the influx of immune cells to eliminate debris, pathogens, and damaged cells. In the proliferative phase, new tissue is formed through processes like angiogenesis (new blood vessel formation), fibroplasia (formation of fibrous tissue), and epithelialization (covering the wound with new epithelial cells). The final phase is remodeling, where collagen is reorganized, and the wound undergoes maturation to regain strength. Various growth factors, cytokines, and cell types, including fibroblasts and macrophages, play crucial roles in orchestrating these phases. Chronic conditions or factors like diabetes can impair wound healing. Therapeutic approaches may include wound dressings, growth factor application, and tissue engineering strategies to optimize and expedite the healing process. Understanding the intricacies of wound healing is essential for developing effective interventions and improving outcomes in both acute and chronic wound scenarios.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States